[Altavia]

Originally Posted by Altavia

Not when using multiplexed molecular diagnostic tests.

BIOFIRE(R) Syndromic Trends

Hmm, this is interesting.

COVID-19 and the Value of the Syndromic Approach

COVID-19 and the Value of the Syndromic Approach
Study results suggest higher rates of co-infection between SARS-CoV-2 and other respiratory pathogens than previously reported. In some cases, as many as 20% of COVID-19 patients have co-infections with another respiratory virus.3 Because respiratory symptoms are similar and overlapping, a syndromic panel can provide fast, comprehensive answers and take the guesswork out of choosing which pathogens to test for.